Sarah Cannon Research Institute
Dawn Love has a diverse work experience spanning over 15 years. Dawn began their career as a Staff RN at Cincinnati Children's Hospital Medical Center in 2005. After working there for almost two years, they joined Oncology Hematology Care as an Oncology Research Coordinator in 2006. Dawn then moved on to Sarah Cannon Research Institute in 2010, where they held various roles, including Sr Manager, Oncology Strategic Sites, and currently serves as the Director, Site Support Systems. Their expertise lies in the field of oncology research and they have demonstrated consistent growth and progress throughout their career.
Dawn Love's education history can be summarized as follows:
Dawn Love pursued their educational journey in the field of healthcare administration and nursing. In 2003, they attended Good Samaritan College of Nursing & Health Science, where they earned an Associate of Science & Nursing (A.S.) degree. Dawn then continued their studies at the University of Phoenix from 2008 to 2009, obtaining a Bachelor of Science & Nursing (BSN) degree with a focus on Registered Nursing, Nursing Administration, Nursing Research, and Clinical Nursing. Lastly, they pursued a Master of Health Administration (MHA) degree at the University of Phoenix from 2009 to 2011, specializing in Health/Health Care Administration/Management.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.